The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Thoas Fioretos

Thoas Fioretos

Research team manager

Thoas Fioretos

Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.

Author

  • Maria Askmyr
  • Helena Ågerstam
  • Nils Hansen
  • Sandra Gordon
  • Alexandros Arvanitakis
  • Marianne Rissler
  • Gunnar Juliusson
  • Johan Richter
  • Marcus Järås
  • Thoas Fioretos

Summary, in English

Key points IL1RAP is overexpressed on candidate AML stem cells and is a promising target for antibody-based therapy.

Department/s

  • Division of Molecular Medicine and Gene Therapy
  • Division of Clinical Genetics
  • Stem Cell Center
  • Translational Genomic and Functional Studies of Leukemia
  • StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation

Publishing year

2013

Language

English

Pages

3709-3713

Publication/Series

Blood

Volume

121

Issue

18

Document type

Journal article

Publisher

American Society of Hematology

Topic

  • Hematology

Status

Published

Research group

  • Translational Genomic and Functional Studies of Leukemia

ISBN/ISSN/Other

  • ISSN: 1528-0020